Tzuberi, M., Brzezinski, R. Y., Flint, N., Slieman, M., Zornitzki, L., Viskin, D., . . . Laufer-Perl, M. Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function. BMC.
Chicago Style (17th ed.) CitationTzuberi, Maor, et al. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Pre-treatment Reduced Left Ventricular Function. BMC.
MLA (9th ed.) CitationTzuberi, Maor, et al. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Pre-treatment Reduced Left Ventricular Function. BMC.
Warning: These citations may not always be 100% accurate.